<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>$Œ≤^+$ radioactive nuclei created during proton therapy - Health AI Hub</title>
    <meta name="description" content="This research paper investigates the nuclear reactions occurring during proton therapy, specifically focusing on the production of short-lived $Œ≤^+$ emitting ra">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>$Œ≤^+$ radioactive nuclei created during proton therapy</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.09468v1" target="_blank">2511.09468v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-12
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Izabela Skwira-Chalot, Przemys≈Çaw Sekowski, Agata Taranienko, Adam Spyra, Tomasz Matulewicz, Jan Swako≈Ñ, Joanna Matulewicz
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> nucl-ex, physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.09468v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.09468v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This research paper investigates the nuclear reactions occurring during proton therapy, specifically focusing on the production of short-lived $Œ≤^+$ emitting radioisotopes like $^{11}$C, $^{13}$N, and $^{15}$O. The authors measured the cross sections for the creation of these isotopes using various target materials relevant to biological tissues (C, BN, SiO$_2$). Their experimental results, obtained with proton beams below 58 MeV, precisely follow previously established excitation functions with high accuracy (a few percent uncertainty), contributing crucial data for in-beam Positron Emission Tomography (PET) applications.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Precise knowledge of these $Œ≤^+$ emitter production cross sections is critical for the advancement of in-beam Positron Emission Tomography (PET) techniques in proton therapy. This technology allows for real-time, non-invasive verification of the proton beam's stopping range and deposited dose, directly enhancing treatment accuracy and patient safety in cancer care.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The data presented (cross-section measurements for in-situ PET isotope production) could be used to train and validate AI models for several health applications: 
1. **AI-driven Treatment Planning Systems:** To more accurately predict dose distribution, secondary radiation, and activation products within the patient during proton therapy, optimizing treatment plans for efficacy and safety. 
2. **AI-enhanced Range Verification:** Machine learning algorithms could be developed to analyze the spatial and temporal distribution of these short-lived $Œ≤^+$ emitters, detected via in-beam PET or prompt gamma imaging, to provide real-time feedback on proton beam range and verify target coverage, significantly improving treatment accuracy. 
3. **AI for Quality Assurance:** AI models could monitor and analyze the activation patterns to detect deviations from expected dose delivery, indicating potential issues with treatment delivery.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Inelastic nuclear reactions occur during proton therapy, with approximately 25% of protons initiating these reactions at the highest therapeutic energies.</li>
                    
                    <li>The study specifically measured the proton-induced production cross sections for three $Œ≤^+$ emitting radioisotopes: $^{11}$C, $^{13}$N, and $^{15}$O.</li>
                    
                    <li>These radioisotopes are short-lived, with half-lives ranging from 2 to 20 minutes, making them suitable for real-time, in-situ monitoring applications.</li>
                    
                    <li>Experiments utilized solid carbon (C), boron nitride (BN), and silicon dioxide (SiO$_2$) targets, chosen to represent materials found in biological tissues or surrounding detector components.</li>
                    
                    <li>A stack irradiation technique was employed, simultaneously exposing up to 15 targets to proton beams with kinetic energies below 58 MeV generated by a cyclotron.</li>
                    
                    <li>The measured cross sections accurately reproduce the excitation functions established in previous experiments, demonstrating a high level of precision with uncertainties of only a few percent.</li>
                    
                    <li>Understanding these production cross sections is fundamental for the development and optimization of in-beam PET systems used for proton range and dose verification in cancer therapy.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>Stacks comprising up to 15 solid targets (C, BN, and SiO$_2$) were simultaneously irradiated with proton beams delivered by the AIC-144 cyclotron. The kinetic energy of the proton beams was kept below 58 MeV. Following irradiation, the activities of the produced $Œ≤^+$ emitters ($^{11}$C, $^{13}$N, $^{15}$O) were measured to determine their respective production cross sections.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study successfully measured the cross sections for the proton-induced production of short-lived $Œ≤^+$ emitters, specifically $^{11}$C, $^{13}$N, and $^{15}$O. These newly measured cross sections were found to be in excellent agreement with previously established excitation functions, with a high degree of precision, yielding an uncertainty of only a few percent.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The accurate measurement of these radioisotope production cross sections has a direct clinical impact by providing essential data for the design and calibration of in-beam PET systems. These systems enable real-time monitoring of the proton beam's range and deposited dose during treatment, thereby facilitating precise proton therapy delivery, minimizing irradiation of healthy tissue, and potentially improving patient outcomes in cancer treatment.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations. The scope of the measurements is confined to proton energies below 58 MeV and specific target materials (C, BN, SiO$_2$), which may not fully represent the complete spectrum of higher therapeutic energies or the diverse elemental composition of all human tissues.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions. However, the implications of this work strongly suggest continued efforts in optimizing and validating in-beam PET systems for clinical proton range verification, and potentially expanding cross-section measurements to a broader range of clinically relevant proton energies and other nuclei present in human tissues.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation oncology</span>
                    
                    <span class="tag">Medical physics</span>
                    
                    <span class="tag">Nuclear medicine</span>
                    
                    <span class="tag">Cancer therapy</span>
                    
                    <span class="tag">Diagnostic imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Proton therapy</span>
                    
                    <span class="tag tag-keyword">Beta-plus emitters</span>
                    
                    <span class="tag tag-keyword">Nuclear reactions</span>
                    
                    <span class="tag tag-keyword">Cross section</span>
                    
                    <span class="tag tag-keyword">In-beam PET</span>
                    
                    <span class="tag tag-keyword">Radioisotopes</span>
                    
                    <span class="tag tag-keyword">Range verification</span>
                    
                    <span class="tag tag-keyword">Medical physics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">During proton therapy, the beam flux decreases due to inelastic interactions with nuclei. At the highest energies used in proton therapy around 25\% protons initiate nuclear reactions. This report presents the cross section measurements of proton-induced production of three $Œ≤^+$ emitters -- $^{11}$C, $^{13}$N, $^{15}$O -- with half-lives between 2 and 20 minutes, using solid C, BN and SiO$_2$ targets. Stacks of up to 15 targets were irradiated simultaneously with proton beams of kinetic energy below 58 MeV at the AIC-144 cyclotron of the Institute of Nuclear Physics, Polish Academy of Sciences. The measured cross sections follow the excitation function obtained in the previous experiments, with uncertainty of a few percent.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Proceedings for 2nd Symposium on new trends in Nuclear and Medical Physics, 8 pages, 3 figures, accepted for publication in Acta Physics Polonica A</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>